OUR TEAM

Meet Balliscor team



Founded in 2010 by Dr. Alex Mihailidis and Dr. Isaac S. Chang, the company originated as a research endeavor. Their observations of cognitively challenged patients struggling with simple tasks highlights the significance of effortless heart failure care. Dr. Suzanna Mak's entry as a clinical partner marked a pivotal moment, giving rise to Balliscor Inc.

OUR VALUES

Fostering diversity and inclusivity

A cornerstone of Balliscor is its commitment to fostering diversity and inclusivity. The central focus remains on extending remote monitoring choices, thus bridging healthcare gaps between urban centres and rural areas.

OUR VISION

Crafting unobtrusive monitoring solutions with minimal engagement.

Through our innovative SmartTile device, our core aim is to craft unobtrusive monitoring solutions requiring minimal user engagement.

12

International

Peer-reviewed

Publications

Multiple iterations

Prototype Development

$600K

Research Funding Granted

Grants offered by:

CIHR (Canadian Institutes of Health Research)

NSERC (Natural Sciences and Engineering Research Council of Canada)

FedDev (Federal Economic Development Agency for Southern Ontario)

AGE-WELL NCE

Mitacs

Bio Talent

100 Clinical Patients

3rd Clinical Study—ongoing

1st Clinical Study (n=26) - completed in 2019

2nd Clinical Study (n=10) - completed in 2023

US Provisional Patent

to be filed by the end of 2024

OUR COMPANY

Care Solution for Heart Failure Patients.

Balliscor, a biomedical company, is helping to improve the lives of heart failure patients through its SmartTile device.

CONNECT

600 University Ave,

Toronto, ON M5G 1X5

FOLLOW US

Linkedin

© 2024 by Balliscor Inc.

ABOUT US

Our company

Our product

Careers

Our team

CONNECT

600 University Ave,

Toronto, ON M5G 1X5

www.balliscor.com

Contact@Balliscor.com

FOLLOW US

Linkedin

© 2024 by Balliscor Inc.

OUR TEAM

Meet Balliscor team

Founded in 2010 by Dr. Alex Mihailidis and Dr. Isaac S. Chang, the company originated as a research endeavor. Their observations of cognitively challenged patients struggling with simple tasks highlights the significance of effortless heart failure care. Dr. Suzanna Mak's entry as a clinical partner marked a pivotal moment, giving rise to Balliscor Inc.

Alex Mihailidis. PhD, PEng.

Scientific Advisor

Isaac S Chang. PhD

Founder

Susanna Mak. MD, PhD

Clinical Advisor

OUR VALUES

Fostering diversity and inclusivity

SmartTile is an unobtrusive and autonomous care solution that monitors the patient during sleep without wearables or any contact with the body.

OUR VISION

Crafting unobtrusive monitoring solutions with minimal engagement.

Through our innovative SmartTile device, our core aim is to craft unobtrusive monitoring solutions requiring minimal user engagement.

12

International

Peer-reviewed

Publications

Multiple-iterated

Generation Prototype

US Provisional

Patent

to be filed by the end of 2024

100 Sample

3rd Clinical Study—ongoing

$600K

Research Funding Granted

Grants offered by:

CIHR

(Canadian Institutes of Health Research)

NSERC

(Natural Sciences and Engineering Research Council of Canada)

FedDev

(Federal Economic Development Agency for Southern Ontario)

AGE-WELL NCE

Mitacs

Bio Talent

OUR COMPANY

Care Solution for

Heart Failure Patients

Balliscor, a biomedical company, is helping to improve the lives of heart failure patients through its SmartTile device.

OUR COMPANY

Care Solution for

Heart Failure Patients

Balliscor, a biomedical company, is helping to improve the lives of heart failure patients through its SmartTile device.